These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 33926929)

  • 1. Relief and worry for immune-suppressed people.
    Couzin-Frankel J
    Science; 2021 Apr; 372(6541):443-444. PubMed ID: 33926929
    [No Abstract]   [Full Text] [Related]  

  • 2. BNT162b2 mRNA Covid-19 Vaccine Effectiveness among Health Care Workers.
    Benenson S; Oster Y; Cohen MJ; Nir-Paz R
    N Engl J Med; 2021 May; 384(18):1775-1777. PubMed ID: 33755373
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 vaccination in immunocompromised patients.
    Sonani B; Aslam F; Goyal A; Patel J; Bansal P
    Clin Rheumatol; 2021 Feb; 40(2):797-798. PubMed ID: 33426632
    [No Abstract]   [Full Text] [Related]  

  • 4. Audio Interview: A New mRNA Vaccine.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Jun; 384(25):e109. PubMed ID: 34161714
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19 vaccines for patients with haematological conditions.
    Sun C; Pleyer C; Wiestner A
    Lancet Haematol; 2021 May; 8(5):e312-e314. PubMed ID: 33811822
    [No Abstract]   [Full Text] [Related]  

  • 6. Audio Interview: The Implications of Changes in the Structural Biology of SARS-CoV-2.
    Rubin EJ; Baden LR; Abraham J; Morrissey S
    N Engl J Med; 2021 Mar; 384(10):e48. PubMed ID: 33704945
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19 vaccination: Recommendations for management of patients with allergy or immune-based diseases.
    Peter J
    S Afr Med J; 2021 Feb; 111(4):291-294. PubMed ID: 33944757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vaccination against SARS-CoV-2 in patients with multiple sclerosis].
    Costa Frossard-França L; García-Domínguez JM; Moreno-Torres I; Fortún J; Villar LM; Meca-Lallana V
    Rev Neurol; 2021 Apr; 72(7):250-260. PubMed ID: 33764494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Johnson & Johnson Vaccine for COVID-19.
    Livingston EH; Malani PN; Creech CB
    JAMA; 2021 Apr; 325(15):1575. PubMed ID: 33646285
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of immunosuppressive treatment on the immunogenicity of mRNA COVID-19 vaccine in vulnerable patients with giant cell arteritis.
    Delvino P; Bartoletti A; Cassaniti I; Bergami F; Lilleri D; Baldanti F; Bozzalla Cassione E; Biglia A; Montecucco C; Monti S
    Rheumatology (Oxford); 2022 Feb; 61(2):870-872. PubMed ID: 34664631
    [No Abstract]   [Full Text] [Related]  

  • 11. Coronavirus Disease 2019 Vaccination Is Associated With Reduced Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Death in Liver Transplant Recipients.
    John BV; Deng Y; Khakoo NS; Taddei TH; Kaplan DE; Dahman B
    Gastroenterology; 2022 Feb; 162(2):645-647.e2. PubMed ID: 34758352
    [No Abstract]   [Full Text] [Related]  

  • 12. [We must respect the anti-SARS-CoV-2 vaccine schedule without delay in cancer patients under treatment].
    Barrière J; Audigier-Valette C; Borchiellini D; Hoch B; Castelnau O; Francois E; Gastaud L; Skaf R; Berdah JF; Marie W; Lescaut W; Peyrade F; Cluzeau T; Cassuto O; Carles M
    Bull Cancer; 2021 Apr; 108(4):341-342. PubMed ID: 33741139
    [No Abstract]   [Full Text] [Related]  

  • 13. Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review.
    Parker EPK; Desai S; Marti M; Nohynek H; Kaslow DC; Kochhar S; O'Brien KL; Hombach J; Wilder-Smith A
    Lancet Glob Health; 2022 Mar; 10(3):e326-e328. PubMed ID: 35180408
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19 vaccines: what happened to evidence-based medicine?
    Quek E; Tahir H
    Br J Hosp Med (Lond); 2021 Feb; 82(2):1-4. PubMed ID: 33646036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Winter Is Coming! Clinical, Immunologic, and Practical Considerations for Vaccinating Patients With Inflammatory Bowel Disease During the Coronavirus Disease-2019 Pandemic.
    Melmed GY; Rubin DT; McGovern DPB
    Gastroenterology; 2021 Feb; 160(3):639-644. PubMed ID: 33065064
    [No Abstract]   [Full Text] [Related]  

  • 16. Global COVID-19 vaccine inequity.
    Burki T
    Lancet Infect Dis; 2021 Jul; 21(7):922-923. PubMed ID: 34174236
    [No Abstract]   [Full Text] [Related]  

  • 17. Could mixing COVID vaccines boost immune response?
    Ledford H
    Nature; 2021 Feb; 590(7846):375-376. PubMed ID: 33547431
    [No Abstract]   [Full Text] [Related]  

  • 18. Need to promote healthy lifestyle as primary prevention to the COVID-19 and to improve the immune response to vaccines.
    De la Cámara MÁ; Pardos-Sevilla AI; Jiménez-Fuente A; Veiga ÓL
    Acta Biomed; 2020 Nov; 92(1):e2021026. PubMed ID: 33682812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 Vaccination in Pregnant and Lactating Women.
    Adhikari EH; Spong CY
    JAMA; 2021 Mar; 325(11):1039-1040. PubMed ID: 33555297
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.